Distinguished in Gestational Trophoblastic Disease

Luigi Gianolli

Milan, IT 
Distinguished in Gestational Trophoblastic Disease
Milan, IT 
OverviewLocationsClinical Research

Overview

Luigi Gianolli practices in Milan, Italy. Mr. Gianolli is rated as a Distinguished expert by MediFind in the treatment of Gestational Trophoblastic Disease. His top areas of expertise are Gestational Trophoblastic Disease, Prostate Cancer, Cerebral Hypoxia, Endometrial Cancer, and Prostatectomy.

His clinical research consists of co-authoring 113 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Gestational Trophoblastic Disease.

Gender
Male

Locations

Milan, Italy
Other Locations
San Raffaele, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Targeting the Future of Axillary Staging in Node Positive Breast Cancer Patients Receiving Primary Systemic Therapy. A Comparative Study Between Sentinel Node Biopsy vs PET/MRI.
Targeting the Future of Axillary Staging in Node Positive Breast Cancer Patients Receiving Primary Systemic Therapy. A Comparative Study Between Sentinel Node Biopsy vs PET/MRI.
Enrollment Status: Completed
Publish Date: August 01, 2025
Intervention Type: Diagnostic test
Study Phase: Not Applicable

113 Total Publications

Somatostatin receptor activity assessed by 68Ga-DOTATOC PET can preoperatively predict DAXX/ATRX loss of expression in well-differentiated pancreatic neuroendocrine tumors.
Somatostatin receptor activity assessed by 68Ga-DOTATOC PET can preoperatively predict DAXX/ATRX loss of expression in well-differentiated pancreatic neuroendocrine tumors.
Journal: European journal of nuclear medicine and molecular imaging
Published: January 18, 2023

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Gianolli's expertise for a condition
ConditionClose
    View All 7 Advanced Conditions
    View All 29 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile